Health in Korea 1,020 indicators covering health for Korea. IndicatorLatest Year10-yr change Rank External health expenditure (EXT) as percentage of current health 0.0% 2023 β 146th Domestic general government health expenditure (GGHE-D) as percentage 58.6% 2023 up 7.2% 89th Out-of-pocket expenditure as percentage of current health expenditure 31.8% 2023 down 17.0% 79th Domestic general government health expenditure (GGHE-D) as percentage 5.0% 2023 up 51.3% 51st Domestic general government health expenditure (GGHE-D) as percentage 15.6% 2023 up 35.5% 37th Domestic private health expenditure (PVT-D) as percentage of current 41.4% 2023 down 8.6% 81st Current health expenditure (CHE) per capita in US$ 3,044 2023 up 75.1% 29th Domestic private health expenditure (PVT-D) per capita in US$ 1,261 2023 up 59.9% 14th Domestic general government health expenditure (GGHE-D) per capita in 1,783 2023 up 87.6% 33rd Total healthcare expenditure gdp 8.57 2023 up 41.1% 50th Health expenditure government expenditure 15.62 2023 up 35.5% 37th Mumps - number of reported cases 6,718 2025 down 60.5% 10th Hib vaccine 97 2024 unchanged 29th Congenital Rubella Syndrome - number of reported cases 0 2025 β 16th External health expenditure (EXT) per capita in US$ 0 2023 β 149th Dentists 28,392 2023 up 26.3% 22nd Nursing and midwifery personnel 506,970 2024 up 78.6% 12th Nursing personnel 506,970 2024 up 79.2% 12th Raised blood pressure (SBP>=140 OR DBP>=90) 12.68 2019 down 28.2% 191st Raised blood pressure (SBP>=140 OR DBP>=90) 13.83 2019 down 22.6% 191st Hypertension: diagnosis coverage among adults aged 30-79 with 71.1% 2019 up 17.5% 16th Hypertension among adults aged 30-79 years, prevalence 26.7 2019 down 5.7% 183rd Hypertension effective treatment coverage (controlled hypertension) 52.6% 2019 up 39.9% 2nd Hypertension: effective treatment coverage (controlled hypertension) 55.4% 2019 up 47.3% 2nd Hypertension treatment coverage among adults aged 30-79 with 74.7% 2019 up 24.5% 2nd Hypertension treatment coverage among adults aged 30-79 with 71.1% 2019 up 18.3% 3rd Hypertension: diagnosis coverage among adults aged 30-79 with 74.7% 2019 up 23.7% 11th Hypertension among adults aged 30-79 years, prevalence, crude 31 2019 up 8.4% 152nd Pneumococcal conjugate second or third-dose vaccines (PCVc) 97.0% 2025 unchanged 16th Adolescent birth rate 0.0089 2022 β 141st Rubella number unvaccinated 7,631 2023 up 66.7% 85th Estimated number of malaria cases 640 Cases 2024 up 14.9% 70th Treatment success rate: previously treated TB cases 77 2023 up 4.1% 59th Medical doctors 26.63 2023 up 22.4% 72nd Prevalence of insufficient physical activity among adults aged 18+ 60.7% 2022 up 38.2% 4th Prevalence of insufficient physical activity among adults aged 18+ 58.1% 2022 up 36.4% 5th Nursing and midwifery personnel 98.03 2024 up 74.5% 22nd Immunization measles vs vaccine safety 96 2024 unchanged 25th Share of children vaccinated with mcv2 96 2024 unchanged 25th Cases of paralytic polio from vaccine derived viruses 0 2023 β 24th Cases of paralytic polio from wild vs vaccine derived viruses 0 2023 β 24th Dentists 5.49 2023 up 22.3% 57th Confirmed cases of RR-/MDR-TB 461 2024 down 60.7% 32nd Hib3 number unvaccinated 10,175 2023 down 24.7% 97th Share of deaths from cardiovascular diseases men women 16.74 2022 down 11.3% 109th Deaths registered with an ill defined cause of death 11.8 2022 up 26.0% 20th Share of deaths from homicide 0.0858 2022 down 57.7% 80th Share of deaths from major causes 3.78 2022 down 10.3% 59th Share of deaths from underlying causes 22.81 2022 down 18.7% 35th Cause of death, by other COVID-19 pandemic-related outcomes, ages 0-4 0.0% 2021 β 3rd Cause of death, by other COVID-19 pandemic-related outcomes, ages 5-14 0.0% 2021 β 104th Cause of death, by other COVID-19 pandemic-related outcomes, ages 5-14 0.0% 2021 β 112th Cause of death, by other COVID-19 pandemic-related outcomes, ages 5-14 0.0% 2021 β 112th Cause of death, by other COVID-19 pandemic-related outcomes, ages 15-5 0.0% 2021 β 115th Cause of death, by other COVID-19 pandemic-related outcomes, ages 15-5 0.0% 2021 β 115th Cause of death, by other COVID-19 pandemic-related outcomes, ages 15-5 0.0% 2021 β 115th Cause of death, by other COVID-19 pandemic-related outcomes, ages 60+ 0.0% 2021 β 115th Cause of death, by other COVID-19 pandemic-related outcomes, ages 60+ 0.0% 2021 β 115th Cause of death, by other COVID-19 pandemic-related outcomes, ages 60+ 0.0% 2021 β 115th Cause of death, by other COVID-19 pandemic-related outcomes, female 0.0% 2021 β 116th β Previous Page 10 of 17 Next β